• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association between virological response and decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in HCV genotype 1: another story.

作者信息

Dai Chia-Yen, Huang Chung-Feng, Huang Jee-Fu, Chuang Wan-Long, Yu Ming-Lung

出版信息

Hepatology. 2011 May;53(5):1774-5; author reply 1775-6. doi: 10.1002/hep.24204.

DOI:10.1002/hep.24204
PMID:21520186
Abstract
摘要

相似文献

1
Association between virological response and decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in HCV genotype 1: another story.
Hepatology. 2011 May;53(5):1774-5; author reply 1775-6. doi: 10.1002/hep.24204.
2
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1.聚乙二醇干扰素和利巴韦林治疗丙型肝炎病毒 1 型时，病毒学应答与血红蛋白浓度下降相关。
Hepatology. 2011 Apr;53(4):1109-17. doi: 10.1002/hep.24180.
3
Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.特拉匹韦可成功且安全地用于治疗基因型 1b 慢性丙型肝炎的老年患者。
J Hepatol. 2013 Aug;59(2):205-12. doi: 10.1016/j.jhep.2013.03.020. Epub 2013 Mar 28.
4
Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis.患者摘要。聚乙二醇化干扰素联合或不联合利巴韦林用于接受血液透析的丙型肝炎患者。
Ann Intern Med. 2013 Dec 3;159(11):I-14. doi: 10.7326/0003-4819-159-11-201312030-00001.
5
Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment.慢性丙型肝炎患者在利巴韦林和聚乙二醇干扰素治疗期间内源性促红细胞生成素反应不佳。
Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1308-15. doi: 10.1097/MEG.0b013e32833e784d.
6
Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.聚乙二醇干扰素 alfa-2a 联合或不联合低剂量利巴韦林治疗初治丙型肝炎病毒基因型 2 接受血液透析的患者：一项随机试验。
Gut. 2015 Feb;64(2):303-11. doi: 10.1136/gutjnl-2014-307080. Epub 2014 Apr 19.
7
Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response.在丙型肝炎病毒感染与利巴韦林联合治疗中使用促红细胞生成素β可提高持续病毒应答率。
J Med Virol. 2010 Jan;82(1):49-56. doi: 10.1002/jmv.21657.
8
HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirin.HLA - B*15:02与接受聚乙二醇化干扰素-α和利巴韦林治疗的慢性丙型肝炎患者的贫血相关。
Tissue Antigens. 2012 Nov;80(5):424-30. doi: 10.1111/j.1399-0039.2012.01956.x. Epub 2012 Aug 30.
9
Very short course of triple therapy including telaprevir for chronic hepatitis C: a possible strategy in selected patients.含替拉瑞韦的极短疗程三联疗法治疗慢性丙型肝炎：特定患者的一种可能策略。
Int J Infect Dis. 2014 Feb;19:85-6. doi: 10.1016/j.ijid.2013.09.002. Epub 2013 Oct 25.
10
Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trial.聚乙二醇干扰素和利巴韦林延长疗程治疗基因型 3 丙型肝炎和晚期纤维化患者：STEP 试验的最终结果。
J Hepatol. 2014 Apr;60(4):699-705. doi: 10.1016/j.jhep.2013.11.011. Epub 2013 Nov 26.